SCHEMBL31489760

SCHEMBL31489760

C[C@H](c1ccc(F)cc1)n1cc(-c2cc(C(F)(F)F)cc(-c3ccn4nc(N)nc4c3)n2)cn1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 10/20 0.36
PIK3CD O00329 8/20 0.36
RIPK1 Q13546 5/20 0.36
PAK4 O96013 1/20 0.34
JAK1 P23458 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
CSNK1A1 P48729 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
PIP4K2C Q8TBX8 1/20 0.34
CSNK1G1 Q9HCP0 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
CREBBP Q92793 2/20 0.33
HSP90AA1 P07900 1/20 0.33
NTRK1 P04629 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31489855 1.00 PIK3CG (0.36) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489363 0.92 PIK3CG (0.39) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489747 0.89 PIK3CG (0.37) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489430 0.89 RIPK1 (0.41) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489729 0.89 PIK3CG (0.42) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489628 0.89 RIPK1 (0.41) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489643 0.88 PIK3CG (0.40) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489298 0.88 PIK3CG (0.40) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489868 0.84 PIK3CG (0.39) PIK3CGPIK3CDRIPK1PAK4JAK1
SCHEMBL31489621 0.83 RIPK1 (0.44) PIK3CGPIK3CDRIPK1PAK4JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072395-A1 TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-04-03 WO disclosed